C-Suite Transitions – CEO Transitions at Netflix
Welcome to edition 25 of C-Suite Transitions, a weekly series on InsideArbitrage that tracks appointments and departures at publicly traded companies during the prior week. We highlight five appointments and departures each week by picking the largest companies from the full list of management changes.
- NeuroBo Pharmaceuticals (NRBO): On January 12, 2023, Gil Price, M.D. resigned as Chief Executive Officer and President, effective immediately.
- NetFlix (NFLX): On January 13, 2023, Reed Hastings stepped down as CO-CEO of the company, effective immediately.
- Catalyst Biosciences (CBIO): On January 15, 2023, Catalyst Biosciences terminated Grant Blouse Ph.D. from his position as the Chief Scientific Officer, effective as of January 15, 2023.
Please subscribe for free or login to your InsideArbitrage account to access this article.
